Journals / Respiratory Case Reports / 2018 / Cilt: 7 - Sayı: 1

A Rare Cause of Acute Respiratory Failure: Myasthenic Crisis

Akut Solunum Yetmezliğinin Nadir Bir Nedeni: Myastenik Kriz

Pages
47–49
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case is presented as myasthenic crisis as a rare cause of acute respiratory failure.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Myasthenia gravis is a muscle disorder characterized by weakness and rapid fatigue in the skeletal muscles.
📊
Key Findings & Data:Pyridostigmine 120 mg 3x1 and 1 mg/kg/day prednisolone were administered.
💡
Conclusion & Impact:This case is presented as myasthenic crisis as a rare cause of acute respiratory failure.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Myasthenia gravis is a muscle disorder characterized by weakness and rapid fatigue in the skeletal muscles. Myasthenic crisis can develop for various reasons. In this case report, a patient with respiratory distress and a myasthenic crisis who required urgent hospital admission and intensive care unit is described. He had a history of diabetes mellitus, hypertension, coronary artery bypass graft surgery, and a thymectomy due to myasthenia gravis. The patient required mechanical ventilator support in the intensive care unit as a result of acute respiratory failure due to myasthenic crisis. Pyridostigmine 120 mg 3x1 and 1 mg/kg/day prednisolone were administered. Intravenous immunoglobulin was given at a dose of 2 g/kg for 5 days. The patient was removed from the mechanical ventilator on the third day of the intensive care admission. This case is presented as myasthenic crisis as a rare cause of acute respiratory failure.

Özet

Miyastenia gravis, iskelet kaslarında güçsüzlük ve çabuk yorulma ile karakterize bir kas hastalığıdır. Miyastenik hastalarda çeşitli nedenlerle miyastenik kriz gelişebilir. Bu olgu sunumunda solunum sıkıntısı ile acil servise başvuran ve yoğun bakım yatışı gerektiren miyastenik krizli bir hasta ele alınmıştır. Özgeçmişinde, diabestes mellitus, hipertansiyon, koroner arter bypass grefti operasyonu ve miyastenia gravis nedeniyle timektomi öyküsü vardı. Hasta yoğun bakımda mekanik ventilatör desteğinde izleme alındı. Hastada myastenik krize bağlı akut solunum yetmezliği düşünüldü. Pridostigmin 120 mg 3x1 olarak ve 1 mg/kg/gün prednizolon başlandı. İntravenöz immün globülin (IVIG) 2 gr/kg dozunda 5 gün süreyle verilmesi planlandı. Yoğun bakım yatışının 3. gününde mekanik ventilatörden ayrıldı. Akut solunum yetmezliğinin nadir bir nedeni olarak miyastenik krizli bu olguyu sunmayı amaçladık.

🔖

Cite This Article

ÇAKMAK, M. E., ER, S., ADEMOĞLU, D., DAL, H. C., SARI, S., TEZCAN, B., KAZANCI, D., TURAN, S. (2018). A Rare Cause of Acute Respiratory Failure: Myasthenic Crisis. Respiratory Case Reports, Cilt: 7 - Sayı: 1, 47–49. https://ajindex.com/articles/302451

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Kumar V, Cotran R, Robbins S. The musculoskeletal system: Myasthenia gravis. Basic Pathology. 5th ed. Philadelphia: Sounders Co; 1992:698-99
  2. Gajdos P, Chevret S, Toyka KV. Intavenous immunoglobulin for myasthenia gravis. Cochrane Database Syst Rev. 2012;12:CD002277. [CrossRef] 3. Long RR. Myasthenia gravis in the intensive care unit. In: Rippe JM, ed. Intensive care medicine. NewYork:Little and Brown Company; 1996:2038-43
  3. Şahinoğlu AH. Yoğun Bakım Sorunları ve Tedavileri. Ankara: Türkiye Klinikleri Yayınları; 2003: 877-80
  4. Thomas CE, Mayer SA, Gungor Y, Swarup R, Webster EA, Chang I, et al. Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology 1997; 48:1253-60. [CrossRef] 6. Spillane J, Higham E, Kullmann DM. Myasthenia gravis. BMJ 2012; 345:e8497. [CrossRef] 7. Bedlack RS, Sanders DB. How to handle myasthenic crisis. Essential steps in patient care. Postgrad Med 2000; 107: 211-4
  5. Provencio JJ, Bleck TP, Connors AF Jr. Critical care neurology. Am J Respir Crit Care Med 2001; 164:341-5. [CrossRef] 9. Mishra SK, Krishnappa S, Bhat RR, Badhe A. Role of intermittent noninvasive ventilation in anticholinesterase dose adjustment for myasthenic crisis. Acta Anaesthesiol Taiwan 2010; 48:53-4. [CrossRef] 10. Piastra M, Conti G, Caresta E, Tempera A, Chiaretti A, Polidori G, et al. Noninvasive ventilation options in pediatric myasthenia gravis. Paediatr Anaesth 2005; 15:699-702. [CrossRef] 11. Berrouschot J, Baumann I, Kalischewski P, Sterker M, Schneider D. Therapy of myasthenic crisis. Crit Care Med 1997; 25:1228–35. [CrossRef] 12. Yeh JH, Chiu HC. Plasmapheresis in myasthenia gravis. A comparative study of daily versus alternately daily schedule. Acta Neurol Scand 1999; 99:147-51.